Cargando…
Pharmacological management of bipolar disorder: Japanese expert consensus
OBJECTIVES: The aim of this study was to develop a consensus guideline by certified experts of the Japanese Society of Clinical Neuropsychopharmacology on the psychopharmacological treatment for bipolar disorders I and II (BP‐I and BP‐II), in order to fill the gap in the literature and provide more...
Autores principales: | Sakurai, Hitoshi, Kato, Masaki, Yasui-Furukori, Norio, Suzuki, Takefumi, Baba, Hajime, Watanabe, Koichiro, Inada, Ken, Kishida, Ikuko, Sugawara Kikuchi, Yuka, Kikuchi, Toshiaki, Katsuki, Asuka, Uchida, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818260/ https://www.ncbi.nlm.nih.gov/pubmed/32558145 http://dx.doi.org/10.1111/bdi.12959 |
Ejemplares similares
-
Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2021) -
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
por: Tsuboi, Takashi, et al.
Publicado: (2020) -
Management of unspecified anxiety disorder: Expert consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2023) -
Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey
por: Adachi, Naoto, et al.
Publicado: (2023) -
Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2011)